UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of report (Date of earliest event reported)      April 27, 2006
                                                             -------------------

                              Diomed Holdings, Inc.
--------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)

<TABLE>
<CAPTION>
<S>                                                  <C>                                 <C>
               Delaware                              000-32045                            84-1480636
--------------------------------------- ------------------------------------ -------------------------------------
(State or Other Jurisdiction of                     (Commission                        (I.R.S. Employer
 Incorporation)                                     File Number)                      Identification No.)

1 Dundee Park, Andover, Massachusetts                                              01810
---------------------------------------------------------- -------------------------------------------------------
(Address of Principal Executive Offices)                                         (Zip Code)
</TABLE>

                                 (978) 475-7771
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                 Not Applicable
--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

      Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 7.01.  REGULATION FD DISCLOSURE.
            ------------------------

On April 27, 2006, the Company issued a press release, setting forth its
earnings results for the quarterly period ended March 31, 2006 (a copy of which
is attached as Exhibit 99.1 to this Current Report).

ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS
            ---------------------------------

99.1             Press Release, dated April 27, 2006

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                          Diomed Holdings, Inc.
                                          (Registrant)

Date:    April 28, 2006                   By:    /s/ David B. Swank
                                                 ----------------------------
                                          Name:  David B. Swank
                                          Title: Chief Financial Officer

List of Exhibits:

99.1             Press Release, dated April 27, 2006
{"company-data": {"conformed-name": "DIOMED HOLDINGS INC", "cik": "0001074874", "assigned-sic": "3841", "irs-number": "841480636", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31250", "film-number": "06790717"}, "business-address": {"street1": "1 DUNDEE PARK", "city": "ANDOVER", "state": "MA", "zip": "01810", "phone": "978-475-7771"}, "former-company": {"former-conformed-name": "NATEXCO CORP", "date-changed": "20001128"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of report (Date of earliest event reported)      April 27, 2006
                                                             -------------------

                              Diomed Holdings, Inc.
--------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)
Delaware                              000-32045                            84-1480636
--------------------------------------- ------------------------------------ -------------------------------------
(State or Other Jurisdiction of                     (Commission                        (I.R.S. Employer
 Incorporation)                                     File Number)                      Identification No.)

1 Dundee Park, Andover, Massachusetts                                              01810
---------------------------------------------------------- -------------------------------------------------------
(Address of Principal Executive Offices)                                         (Zip Code)
(978) 475-7771
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                 Not Applicable
--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

      Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01.  REGULATION FD DISCLOSURE.
            ------------------------

On April 27, 2006, the Company issued a press release, setting forth its
earnings results for the quarterly period ended March 31, 2006 (a copy of which
is attached as Exhibit 99.1 to this Current Report).

ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS
            ---------------------------------

99.1             Press Release, dated April 27, 2006

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                          Diomed Holdings, Inc.
                                          (Registrant)

Date:    April 28, 2006                   By:    /s/ David B. Swank
                                                 ----------------------------
                                          Name:  David B. Swank
                                          Title: Chief Financial Officer

List of Exhibits:

99.1             Press Release, dated April 27, 2006